Furthermore, endoglin is an angiogenesis/vascular remodeling participator with its soluble form that tends to be increased in inflammatory/vascular pathological conditions (atherosclerosis, hypertension, type 2 diabetes, and dyslipidaemia) and endothelial injury events [105,106,107]. This evidence concerns the gene ENG and type 2 diabetes mellitus.